Skip to main content

Table 2 Composition and characterization of nanoparticles

From: TAT-modified serum albumin nanoparticles for sustained-release of tetramethylpyrazine and improved targeting to spinal cord injury

Sample

Particle

size (nm)

Polydispersity index

Zeta potential

(mV)

Drug loading (%)

Entrapment efficiency (%)

Blank-NPs

79.07 ± 0.36

0.26 ± 0.01

− 28.50 ± 5.16

–

–

TMP-NPs

122.57 ± 2.30

0.13 ± 0.01

− 22.50 ± 4.27

8.36 ± 0.42

75.54 ± 4.02

TAT-TMP-NPs

163.93 ± 0.38

0.18 ± 0.02

− 26.10 ± 4.55

8.02 ± 0.12

77.27 ± 1.99